Writing

Writing on product systems, fintech infrastructure, market behavior, and leadership lessons from practical execution.

📚 Books

Beyond platform leadership and infrastructure design, I write about trading psychology, financial literacy, and structured market participation.

Both books are published globally on Amazon (Kindle & Paperback editions available).

🟦 The Mind Game of Trading

Mastering Psychology for Consistent Profits
By Sreenivasulu Malkari

Overview

Trading success is rarely limited by strategy. It is limited by psychology.

In The Mind Game of Trading, I distill 15+ years of real-world trading experience into a structured framework for mastering discipline, emotional control, and execution integrity.

The book focuses on:

• Identifying hidden cognitive biases
• Structured journaling & checklist systems
• Emotional risk management
• Practical trading plan templates
• Long-term consistency frameworks

This is not a theory book — it is a practical discipline manual for traders at all levels.

🔗 Available on Amazon (Paperback & Kindle)
👉 https://www.amazon.com/dp/B0FNKGB7W2

🟦 The Stock Market Starter Kit

Learn to Trade Smart in 7 Days
By Sreenivasulu Malkari

Overview

Designed for beginners entering the Indian stock market, this book simplifies complex concepts into a structured 7-day learning framework.

It emphasizes structured thinking, capital protection, and long-term consistency as the core pillars of intelligent market participation.

It covers:

• How stock markets function (NSE/BSE context)
• Intraday, swing & long-term trading basics
• Risk management principles
• Chart reading fundamentals
• Practical checklists and action plans

Clear. Structured. Actionable.

🔗 Available on Amazon (Paperback & Kindle)
👉 https://www.amazon.com/dp/B0FF2NK8MV



  • IBPS PO Prelims Result 2025 Out: Direct Link & Cut Off Trends

    IBPS PO Prelims Result 2025 out! Check direct link, cut off, scorecard details, and what’s next for the October 12 mains exam. If you’ve appeared for the IBPS PO Prelims 2025, chances are you’ve been refreshing the official website every few hours, waiting for the results. The anxiety is real — because this exam isn’t…


  • Should You Invest in Jinkushal Industries IPO? All You Need to Know

    Jinkushal Industries IPO: Check GMP, subscription status, price band, strengths, risks, and expert views to decide whether to invest for listing gains or long term. If you’ve been tracking IPO news lately, you’ve probably heard about Jinkushal Industries IPO. The buzz is real — the issue got fully subscribed on Day 1 itself and has…


  • Why TCS Share Price is Falling: Real Reasons Behind the Decline

    Why is TCS share price falling? Explore the real reasons behind TCS’s decline, from FII selling to sector weakness, and what it means for investors. If you’ve been tracking the stock market lately, one question might be nagging you: Why is TCS share price falling so sharply despite being India’s most trusted IT giant? For…


  • Accenture Layoffs 2025: The Harsh Truth Behind AI Restructuring

    Accenture layoffs 2025: Over 11,000 employees let go amid AI restructuring. Explore reasons, impact, and what it means for India’s IT future. Imagine this: You’ve worked for years at one of the biggest IT consulting firms in the world. Suddenly, one morning, you receive an email saying your role no longer exists. Why? Because artificial…


  • “Sun Pharma, Cipla, and Dr. Reddy’s Under the Tariff Lens: Expert Insights”

    Explore how Trump’s 100% pharma tariff affects Indian pharmaceutical companies like Sun Pharma, Cipla, and Dr. Reddy’s, with key insights for investors. Imagine you’re running a business where nearly half your revenue comes from one foreign market, and suddenly, overnight, a 100% tax is slapped on your products. That’s exactly the situation Indian pharmaceutical companies…


  • “Trump’s 100% Pharma Tariff: What It Means for Indian Pharma Drugmakers”

    Explore the implications of President Trump’s 100% tariff on branded drugs for Indian pharmaceutical companies like Sun Pharma, Cipla, and Dr. Reddy’s. In a bold move that has sent ripples through the global pharmaceutical industry, President Donald Trump announced a 100% tariff on imported branded and patented drugs, effective October 1, 2025. This decision has…


Scroll to Top